Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer-Reference-Cited by-同舟云学术

Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer

Published:2022-12 Issue: Volume:243 Page:114704
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Akl Laila,Abd El-Hafeez Amer Ali,Ibrahim Tamer M.,Salem Rofaida,Marzouk Hala Mohamed M.,El-Domany Ramadan A.,Ghosh Pradipta,Eldehna Wagdy M.^ORCID,Abou-Seri Sahar M.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference48 articles.

1. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers;Dyba;Eur. J. Cancer,2021

2. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma;Tempero,2016

3. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma;Margaret,2019

4. A historical overview of protein kinases and their targeted small molecule inhibitors;Roskoski;Pharmacol. Res.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of new benzothiazole-piperazine derivatives and in vitro and in silico investigation of their anticancer activity;Journal of Molecular Structure;2025-01

2. Thioamides in medicinal chemistry and as small molecule therapeutic agents;European Journal of Medicinal Chemistry;2024-11

3. Synthesis, biological evaluation, and molecular docking studies of novel N-substituted piperazine-tethered thiophene-3-carboxamide selenides as potent antiproliferative agents with EGFR kinase inhibitory activity;Bioorganic Chemistry;2024-10

4. Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches;Medicine;2024-08-02

5. Deriving general structure–activity/selectivity relationship patterns for different subfamilies of cyclin-dependent kinase inhibitors using machine learning methods;Scientific Reports;2024-07-03